NCT00096603View on ClinicalTrials.gov

A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

July 31, 2004

Conditions
Psoriasis
Interventions
DRUG

Raptiva (efalizumab)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY